September 18, 2025
September 10, 2025
July 3, 2025
January 10, 2025
Top 10 Pharma Companies in India by Market Cap 2026 | Latest Rankings
Author
Shoonya Team
The Indian pharmaceutical industry continues to expand, supported by strong exports, manufacturing capabilities, and rising healthcare demand. To help you understand the sector’s leading players, here is a list of the top 10 pharma companies in India by market cap as of June 4, 2026, along with their latest business updates and key highlights.
From India’s No. 1 pharma company, Sun Pharmaceutical, to emerging leaders such as Laurus Labs, these businesses represent some of the largest pharmaceutical companies in India and are closely tracked by investors looking at pharma stocks and long-term healthcare sector growth.
| Rank | Company | Market Cap (₹ Cr) | BSE Code | NSE Symbol |
| 1 | Sun Pharma Industries | 4,26,913.65 | 524715 | SUNPHARMA |
| 2 | Divi’s Laboratories | 1,75,126.99 | 532488 | DIVISLAB |
| 3 | Torrent Pharmaceuticals | 1,46,868.29 | 500420 | TORNTPHARM |
| 4 | Cipla | 1,13,011.36 | 500087 | CIPLA |
| 5 | Zydus Lifesciences | 1,09,050.61 | 532321 | ZYDUSLIFE |
| 6 | Dr Reddy’s Laboratories | 1,05,784.44 | 500124 | DRREDDY |
| 7 | Lupin | 1,02,827.77 | 500257 | LUPIN |
| 8 | Mankind Pharma | 97,124.51 | 543904 | MANKIND |
| 9 | Aurobindo Pharma | 84,924.84 | 524804 | AUROPHARMA |
| 10 | Laurus Labs | 77,048.32 | 540222 | LAURUSLABS |
Top 10 Pharmaceutical Companies in India – An Overview
These top pharma companies in India continue to play a major role in domestic healthcare and global medicine exports.
The list below covers the top 10 pharma companies in India by market cap as of June 2026.
1. Sun Pharmaceutical Industries Ltd.
Mumbai, Maharashtra | Est. 1983 | Market Cap: ₹4,26,913.65 Cr | CMP: ₹1,779.30
India’s largest pharma company by market cap, Sun Pharma, reported FY2026 annual revenue of ₹58,462 crore, marking 11.19% growth year-on-year.
In April 2026, it made its biggest-ever overseas move: Sun Pharma signed a definitive agreement to acquire US-based Organon & Co. in an all-cash deal valued at $11.75 billion, which will significantly expand its women’s health, branded generics, and biosimilars presence across 140+ markets. The deal is expected to close in early 2027.
Sun Pharma remains the top pharma company in India and continues to be regarded by many investors as the best pharma company in India based on market capitalisation and global presence.
2. Divi’s Laboratories Ltd.
Hyderabad, Telangana | Est. 1990 | Market Cap: ₹1,75,126.99 Cr | CMP: ₹6,596.90
A pure-play API and custom synthesis powerhouse, Divi’s exports accounted for 88% of its FY25 revenues at ₹8,237 crore, making it one of the most globally integrated names in the list.
Citi named it their top pick in Indian pharma for 2026, citing strong pipeline catalysts and an expected recovery in generics, projecting revenues to expand three times and EBITDA four times between FY25 and FY30.
Divi’s Laboratories continues to feature among the top 5 pharma companies in India.
3. Torrent Pharmaceuticals Ltd.
Ahmedabad, Gujarat | Est. 1959 | Market Cap: ₹1,46,868.29 Cr | CMP: ₹4,339.50
Torrent posted a 16% rise in Q2FY26 profit to ₹591 crore, with double-digit growth across India, the US, and Brazil.
The stock increased 11% in February 2026 alone, among the top performers in the Nifty Pharma index during that period.
4. Cipla Ltd.
Mumbai, Maharashtra | Est. 1935 | Market Cap: ₹1,13,011.36 Cr | CMP: ₹1,399.00
Cipla is consistently ranked among the top pharmaceutical companies in India due to its diversified portfolio and strong presence across multiple therapeutic segments.
Cipla’s ROE and ROCE are both above 18%, and it offers a balanced mix of growth and valuation with a PE of around 23x. Its global reach, particularly in emerging markets, ensures diversified revenue streams, and its consistent dividend policy adds stability for long-term investors. Export revenues in FY25 stood at ₹15,978 crore, contributing 58% of total revenue.
5. Zydus Lifesciences Ltd.
Ahmedabad, Gujarat | Est. 1952 (as Cadila Healthcare) | Market Cap: ₹1,09,050.61 Cr | CMP: ₹1,083.75
Founded in 1952, Zydus Lifesciences has evolved into one of India’s largest pharmaceutical companies, with a growing presence across domestic and international healthcare markets.
On the regulatory side, Zydus settled a long-running patent dispute with Astellas over its generic Myrbetriq (mirabegron) launch in the US, which had been running since 2024.
6. Dr Reddy’s Laboratories Ltd.
Hyderabad, Telangana | Est. 1984 | Market Cap: ₹1,05,784.44 Cr | CMP: ₹1,267.40
Dr Reddy’s is among the most export-oriented large-cap pharma companies, with exports contributing ₹27,095 crore or 83% of FY25 revenues.
On the portfolio side, the company completed the acquisition of the Stugeron brand from Johnson & Johnson across EMEA regions, strengthening its CNS and anti-vertigo portfolio across 18 markets.
7. Lupin Ltd.
Mumbai, Maharashtra | Est. 1968 | Market Cap: ₹1,02,827.77 Cr | CMP: ₹2,249.00
Lupin Ltd., established in 1968 by Dr Desh Bandhu Gupta, has evolved into one of India’s largest pharmaceutical companies, serving patients across more than 100 countries through its broad range of healthcare products.
Lupin’s FY2026 results showed India Region Formulation sales up 14.5% in Q4, while emerging markets revenues surged 35.2% for the full year.
The Board recommended a 900% dividend.
8. Mankind Pharma Ltd.
New Delhi | Est. 1995 | Market Cap: ₹97,124.51 Cr | CMP: ₹2,352.20
Mankind Pharma Ltd., established in 1995, is one of India’s largest pharmaceutical companies, recognised for making affordable healthcare products accessible across urban and rural markets.
The stock gained over 3% on the February 2026 US-India trade deal news, and it remains among the most widely held domestic pharma names among retail investors.
9. Aurobindo Pharma Ltd.
Hyderabad, Telangana | Est. 1986 | Market Cap: ₹84,924.84 Cr | CMP: ₹1,462.20
Aurobindo Pharma Ltd., established in 1986, has evolved into one of India’s largest pharmaceutical companies, serving global markets through its broad portfolio of generic medicines, APIs, and speciality products
Aurobindo is the most export-dependent company in this list, with 89% of FY25 revenues at ₹28,234 crore coming from overseas markets, making it particularly sensitive to US pricing and tariff dynamics. It was among the biggest gainers when the US-India trade deal was announced in February 2026, jumping 5% as tariff relief gave a direct boost to its business model.
10. Laurus Labs Ltd.
Hyderabad, Telangana | Est. 2005 | Market Cap: ₹77,048.32 Cr | CMP: ₹1,427.20
Founded in 2005, Laurus Labs has grown into a leading pharmaceutical and biotechnology company in India, known for its expertise in APIs, generics, and CDMO services for global pharmaceutical innovators.
The standout performer of the list in recent years. Laurus Labs reported FY2026 revenue of ₹6,813 crore, a 23% increase year-on-year, with EBITDA growing 64% and margins improving to 26.8% from 20.1% in FY25.
Why Is India’s Pharmaceutical Industry Growing So Fast?
India has emerged as one of the world’s most important pharmaceutical hubs, supported by strong manufacturing capabilities, growing exports, and increasing global demand for affordable medicines.
Here are some key facts that highlight the sector’s growth:
- India supplies nearly 20% of the world’s generic medicines by volume.
- The country fulfils around 60% of global vaccine demand.
- Pharmaceutical exports exceed $30 billion annually and reach more than 200 countries worldwide.
- India is home to over 3,000 pharma companies and approximately 10,500 manufacturing facilities.
- The country has the highest number of USFDA-compliant manufacturing plants outside the United States.
- Government initiatives such as the PLI Scheme continue to support investment in pharmaceutical manufacturing and innovation.
- The Indian pharmaceutical industry is projected to reach $130 billion by 2030, making it one of the key future industries in India.
Top pharma companies in India have shown remarkable growth.
Here is the list of the top 10 pharma stocks in India for 2026!
India’s Top 10 Pharma Stocks Ranked by Share Price 2026
| Rank | Company | Stock Price (CMP ₹) |
| 1 | Divi’s Laboratories | 6,596.90 |
| 2 | Torrent Pharmaceuticals | 4,339.50 |
| 3 | Mankind Pharma | 2,352.20 |
| 4 | Lupin | 2,249.00 |
| 5 | Sun Pharma Industries | 1,779.30 |
| 6 | Aurobindo Pharma | 1,462.20 |
| 7 | Laurus Labs | 1,427.20 |
| 8 | Cipla | 1,399.00 |
| 9 | Dr Reddy’s Laboratories | 1,267.40 |
| 10 | Zydus Lifesciences | 1,083.75 |
Conclusion
The top 10 pharma companies in India highlight the scale and competitiveness of the country’s healthcare sector. With strong manufacturing capabilities, global reach, and continued investment in research and development, these companies are helping shape the future of pharmaceuticals in India and abroad.
Interested in India’s leading pharma companies? Start investing with a free Demat account
Top Pharma Stocks in India – FAQs
Sun Pharmaceutical Industries Ltd. is the No. 1 pharma company in India based on market capitalisation, with a market cap of ₹4.27 lakh crore as of June 4, 2026.
The top 10 pharma companies in India by market cap as of June 4, 2026 are Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla, Zydus Lifesciences, Dr. Reddy’s Laboratories, Lupin, Mankind Pharma, Aurobindo Pharma, and Laurus Labs.
Dr. Reddy’s Laboratories is ranked 6th among the top pharma companies in India based on market capitalisation as of June 4, 2026.
The top three pharmaceutical companies in India by market cap are Sun Pharma, Divi’s Laboratories, and Torrent Pharmaceuticals.
Torrent Pharmaceuticals is the third-largest pharmaceutical company in India by market capitalisation as of June 4, 2026.
Both are leading pharmaceutical companies. However, Sun Pharma ranks higher in terms of market capitalisation and remains India’s largest pharmaceutical company, while Cipla is ranked fourth as of June 2026.
As of June 4, 2026, Cipla is ranked 4th among the top pharmaceutical companies in India based on market capitalisation.
The top 5 pharma companies in India by market cap are Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla, and Zydus Lifesciences.
The five largest pharmaceutical companies in India by market capitalisation are Sun Pharmaceutical, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla, and Zydus Lifesciences.
The top 10 largest pharma companies in India by market capitalisation are Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Cipla, Zydus Lifesciences, Dr Reddy’s Laboratories, Lupin, Mankind Pharma, Aurobindo Pharma, and Laurus Labs.
Source: https://www.screener.in/
Disclaimer: This content is for education and awareness purposes only and should not be considered investment advice or a recommendation. Investments in securities markets are subject to market risks. Read all the related documents carefully before investing.
Explore Our Offerings
Stocks
Trade equities across NSE and BSE with zero delivery charges. Invest, hold or sell with a seamless experience.
Future & Options
Execute complex strategies with simple tools and real-time data.
IPOs
Apply to the latest IPOs in just a few taps. Stay updated and capture opportunities as they open.